3D Humanized Bioprinted Tubulointerstitium Model to Emulate Renal Fibrosis In Vitro

• Published in: Advanced healthcare materials 2024-11, Vol.13 (29), p.e2400807-n/a
• Main Authors: Addario, Gabriele, Fernández‐Pérez, Julia, Formica, Chiara, Karyniotakis, Konstantinos, Herkens, Lea, Djudjaj, Sonja, Boor, Peter, Moroni, Lorenzo, Mota, Carlos
• Format: Article
• Language: English
• Subjects: Animal models; Animals; bioprinting; Bioprinting - methods; Biopsy; Cell culture; Crosslinking; Deposition; Drug screening; Extracellular matrix; Extracellular Matrix - metabolism; Fibrosis; Growth factors; Human tissues; Humans; in vitro model; In vivo methods and tests; kidney; Kidney - metabolism; Kidney - pathology; Kidney diseases; Mechanical properties; Modulus of elasticity; Printing, Three-Dimensional; Renal function; Renal Insufficiency, Chronic - metabolism; Renal Insufficiency, Chronic - pathology; Swine; Three dimensional printing; Tissue engineering; Tissue Engineering - methods; Transforming Growth Factor beta1 - metabolism; Transforming growth factor-b1; tubulointerstitium
• ISSN: 2192-2640; 2192-2659; 2192-2659
• DOI: 10.1002/adhm.202400807

Chronic kidney disease (CKD) leads to a gradual loss of kidney function, with fibrosis as pathological endpoint, which is characterized by extracellular matrix (ECM) deposition and remodeling. Traditionally, in vivo models are used to study interstitial fibrosis, through histological characterization of biopsy tissue. However, ethical considerations and the 3Rs (replacement, reduction, and refinement) regulations emphasizes the need for humanized 3D in vitro models. This study introduces a bioprinted in vitro model which combines primary human cells and decellularized and partially digested extracellular matrix (ddECM). A protocol was established to decellularize kidney pig tissue and the ddECM was used to encapsulate human renal cells. To investigate fibrosis progression, cells were treated with transforming growth factor beta 1 (TGF‐β1), and the mechanical properties of the ddECM hydrogel were modulated using vitamin B2 crosslinking. The bioprinting perfusable model replicates the renal tubulointerstitium. Results show an increased Young's modulus over time, together with the increase of ECM components and cell dedifferentiation toward myofibroblasts. Multiple fibrotic genes resulted upregulated, and the model closely resembled fibrotic human tissue in terms of collagen deposition. This 3D bioprinted model offers a more physiologically relevant platform for studying kidney fibrosis, potentially improving disease progression research and high‐throughput drug screening. A perfusable 3D bioprinted humanized model is manufactured including human primary kidney cells and extracellular matrix based bioink, without blending any polysaccharide or supporting bath. This model allows to study kidney fibrosis by investigating the synergy between profibrotic cytokine TGF‐β1 and modulation of the mechanical properties of the matrix with vitamin B2 cosslinking.